133 related articles for article (PubMed ID: 22630169)
1. Use of human amelogenin in molecular encapsulation for the design of pH responsive microparticles.
Bonde JS; Bülow L
BMC Biotechnol; 2012 May; 12():25. PubMed ID: 22630169
[TBL] [Abstract][Full Text] [Related]
2. Random mutagenesis of amelogenin for engineering protein nanoparticles.
Bonde J; Bülow L
Biotechnol Bioeng; 2015 Jul; 112(7):1319-26. PubMed ID: 25664685
[TBL] [Abstract][Full Text] [Related]
3. Dynamic interactions of amelogenin with hydroxyapatite surfaces are dependent on protein phosphorylation and solution pH.
Connelly C; Cicuto T; Leavitt J; Petty A; Litman A; Margolis HC; Gerdon AE
Colloids Surf B Biointerfaces; 2016 Dec; 148():377-384. PubMed ID: 27632699
[TBL] [Abstract][Full Text] [Related]
4. Amyloid structure of high-order assembly of Leucine-rich amelogenin revealed by solid-state NMR.
Ma CW; Zhang J; Dong XQ; Lu JX
J Struct Biol; 2019 Apr; 206(1):29-35. PubMed ID: 29604451
[TBL] [Abstract][Full Text] [Related]
5. Folding, assembly, and aggregation of recombinant murine amelogenins with T21I and P41T point mutations.
Bromley KM; Lakshminarayanan R; Lei YP; Snead ML; Moradian-Oldak J
Cells Tissues Organs; 2011; 194(2-4):284-90. PubMed ID: 21540557
[TBL] [Abstract][Full Text] [Related]
6. Establishment and In Vitro Evaluation of Porous Ion-Responsive Targeted Drug Delivery System.
Liu H; Zhu J; Bao P; Ding Y; Wang J; Du Y; Qu Y; Xu Y
Protein Pept Lett; 2020; 27(11):1102-1113. PubMed ID: 32196437
[TBL] [Abstract][Full Text] [Related]
7. Analysis of secondary structure and self-assembly of amelogenin by variable temperature circular dichroism and isothermal titration calorimetry.
Lakshminarayanan R; Yoon I; Hegde BG; Fan D; Du C; Moradian-Oldak J
Proteins; 2009 Aug; 76(3):560-9. PubMed ID: 19274734
[TBL] [Abstract][Full Text] [Related]
8. Structural changes in amelogenin upon self-assembly and mineral interactions.
Beniash E; Simmer JP; Margolis HC
J Dent Res; 2012 Oct; 91(10):967-72. PubMed ID: 22933608
[TBL] [Abstract][Full Text] [Related]
9. Enamel inspired nanocomposite fabrication through amelogenin supramolecular assembly.
Fan Y; Sun Z; Wang R; Abbott C; Moradian-Oldak J
Biomaterials; 2007 Jul; 28(19):3034-42. PubMed ID: 17382381
[TBL] [Abstract][Full Text] [Related]
10. Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery.
Sajeesh S; Sharma CP
J Biomater Sci Polym Ed; 2007; 18(9):1125-39. PubMed ID: 17931503
[TBL] [Abstract][Full Text] [Related]
11. Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery.
Sajeesh S; Sharma CP
J Biomed Mater Res B Appl Biomater; 2006 Feb; 76(2):298-305. PubMed ID: 16130147
[TBL] [Abstract][Full Text] [Related]
12. The pH dependent amelogenin solubility and its biological significance.
Tan J; Leung W; Moradian-Oldak J; Zeichner-David M; Fincham AG
Connect Tissue Res; 1998; 38(1-4):215-21; discussion 241-6. PubMed ID: 11063029
[TBL] [Abstract][Full Text] [Related]
13. Oral peptide delivery: in-vitro evaluation of thiolated alginate/poly(acrylic acid) microparticles.
Greimel A; Werle M; Bernkop-Schnürch A
J Pharm Pharmacol; 2007 Sep; 59(9):1191-8. PubMed ID: 17883889
[TBL] [Abstract][Full Text] [Related]
14. Design of cationic microspheres based on aminated gelatin for controlled release of peptide and protein drugs.
Morimoto K; Chono S; Kosai T; Seki T; Tabata Y
Drug Deliv; 2008 Feb; 15(2):113-7. PubMed ID: 18293197
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the capacity of enamel matrix derivative gel and enamel matrix derivative in liquid formulation to adsorb to bone grafting materials.
Miron RJ; Bosshardt DD; Buser D; Zhang Y; Tugulu S; Gemperli A; Dard M; Caluseru OM; Chandad F; Sculean A
J Periodontol; 2015 Apr; 86(4):578-87. PubMed ID: 25594536
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of proteins in biodegradable polymeric microparticles using electrospray in the Taylor cone-jet mode.
Xie J; Wang CH
Biotechnol Bioeng; 2007 Aug; 97(5):1278-90. PubMed ID: 17216662
[TBL] [Abstract][Full Text] [Related]
17. Zeta-potential and particle size analysis of human amelogenins.
Uskokovic V; Castiglione Z; Cubas P; Zhu L; Li W; Habelitz S
J Dent Res; 2010 Feb; 89(2):149-53. PubMed ID: 20040742
[TBL] [Abstract][Full Text] [Related]
18. Evidence for amelogenin "nanospheres" as functional components of secretory-stage enamel matrix.
Fincham AG; Moradian-Oldak J; Diekwisch TG; Lyaruu DM; Wright JT; Bringas P; Slavkin HC
J Struct Biol; 1995; 115(1):50-9. PubMed ID: 7577231
[TBL] [Abstract][Full Text] [Related]
19. pH-sensitive hydrogels based on bovine serum albumin for oral drug delivery.
Iemma F; Spizzirri UG; Puoci F; Muzzalupo R; Trombino S; Cassano R; Leta S; Picci N
Int J Pharm; 2006 Apr; 312(1-2):151-7. PubMed ID: 16490328
[TBL] [Abstract][Full Text] [Related]
20. The proteolytic processing of amelogenin by enamel matrix metalloproteinase (MMP-20) is controlled by mineral ions.
Khan F; Liu H; Reyes A; Witkowska HE; Martinez-Avila O; Zhu L; Li W; Habelitz S
Biochim Biophys Acta; 2013 Mar; 1830(3):2600-7. PubMed ID: 23201201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
